Table 1.
Patient Characteristics
| Medical Oncology (n=155) | Radiation Oncology (n=69) | HSCT (n=118) | Total (N=342) | |
|---|---|---|---|---|
|
Age: Mean (SD) Median (range) |
58.6 (12.5) 59 (20-86) |
53.7 (14.7) 54 (18-83) |
49.0 (13.0) 51 (19-75) |
54.3 (13.8) 55 (18-86) |
|
Gender: Male, n (%) |
80 (51.6%) |
33 (47.8%) |
72 (61.0%) |
185 (54.1%) |
|
Marital Status: Married or Partnered, n (%) Missing |
105 (67.7%) 1 (0.6%) |
53 (76.8%) 1 (1.4%) |
76 (64.4%) 2 (1.7%) |
234 (68.4%) 4 (1.2%) |
|
Race: White Asian Pacific Islander Black American Indian Multiple Races Missing |
140 (90.3%) 5 (3.2%) 0 (0.0%) 6 (3.9%) 2 (1.3%) 0 (0.0%) 2 (1.3%) |
63 (91.3%) 5 (7.2%) 0 (0.0%) 0 (0.0%) 1 (1.4%) 0 (0.0%) 0 (0.0%) |
105 (89.0%) 2 (1.7%) 0 (0.0%) 1 (0.8%) 3 (2.5%) 7 (5.9%) 0 (0.0%) |
308 (90.1%) 12 (3.5%) 0 (0.0%) 7 (2.0%) 6 (1.8%) 11 (2.0%) 2 (0.6%) |
|
Ethnicity: Hispanic/Latino, n (%) Missing |
3 (1.9%) 5 (3.2%) |
2 (2.9%) 4 (5.8%) |
2 (1.7%) 3 (2.5%) |
7 (2.0%) 12 (3.5%) |
|
Education: Post-secondary education, n (%) Missing |
106 (68.4%) 3 (1.9%) |
47 (68.1%) 0 (0.0%) |
88 (74.6%) 1 (0.8%) |
241 (70.5%) 4 (1.2%) |
|
Annual Income: $18,000 or less $18,001-35,000 $35,001-55,000 $55,001 or more Missing |
19 (12.3%) 23 (14.8%) 19 (12.3%) 80 (51.6%) 14 (9.0%) |
9 (13.0%) 3 (4.3%) 7 (10.1%) 44 (63.8%) 6 (8.7%) |
12 (10.2%) 20 (16.9%) 56 (47.5%) 10 (8.5%) |
40 (11.7%) 46 (13.5%) 46 (13.5%) 180 (52.6%) 30 (8.8%) |
|
Work Status: Working Not working Retired Missing |
55 (35.5%) 33 (21.3%) 67 (43.2%) 0 (0.0%) |
35 (50.7%) 18 (26.1%) 16 (23.2%) 0 (0.0%) |
16 (13.6%) 74 (62.7%) 27 (22.9%) 1 (0.8%) |
106 (31.0%) 125 (36.5%) 110 (32.2%) 1 (0.3%) |
|
Home Computer Experience Never or rarely Sometimes Often or very often Missing |
29 (18.7%) 26 (16.8%) 99 (63.9%) 1 (0.3%) |
13 (18.8%) 6 (8.7%) 50 (72.5%) 0 (0.0%) |
15 (12.7%) 17 (14.4%) 85 (72.0%) 1 (0.8%) |
57 (16.7%) 49 (14.3%) 234 (68.4%) 2 (0.6%) |
|
Work Computer Experience Never or rarely Sometimes Often or very often Missing |
35 (22.6%) 15 (9.7%) 101 (65.2%) 4 (2.6%) |
13 (18.8%) 3 (4.3%) 44 (63.8%) 9 (13.0%) |
18 (15.3%) 10 (8.5%) 78 (66.1%) 12 (10.2%) |
66 (19.3%) 28 (9.9%) 223 (66.7%) 25 (7.3%) |
|
Cancer Diagnoses: Most common diagnoses, n (%) |
Prostate: 25 (16.1%) Lung: 23 (14.8%) Colorectal: 19 (12.2%) Lymphoma: 13 (8.4%) Ovarian: 8 (5.2%) Other: 67 (43.2%) |
Head and Neck: 18 (26.1%) Breast: 16 (23.2%) Prostate: 6 (8.7%) Skin: 5 (7.2%) Lung: 3 (4.4%) Other: 21 (30.4%) |
Leukemia: 56 (47.5%) Lymphoma: 38 (32.2%) Myeloma: 22 (18.6%) Myelodysplasia: 1 (0.8%) Testicular: 1 (0.8%) Other - 0 (0.0%) |
Leukemia: 59 (17.2%) Lymphoma: 54 (15.8%) Prostate: 31 (9.1%) Lung: 26 (7.6%) Myeloma: 26 (7.6%) Other*: 146 (42.7%) |
| Number of days between T1 & T2 |
44.9 (33.0) |
51.6 (33.7) |
51.7 (18.9) |
48.6 (29.2) |
*
Other diagnoses include: Head and Neck, 23 (6.7%); Colorectal, 20 (5.8%); Breast, 17 (5.0%); Cervical, 9 (2.6%); Pancreatic, 9 (2.6%); Skin, 9 (2.6%); Other, 8 (2.3%); Ovarian, 8 (2.3%); Uterine, 8 (2.3%); Esophageal, 7 (2.0%); Liver, 7 (2.0%); Endometrial, 6 (1.8%); Bladder, 3 (0.9%); Testicular, 3 (0.9%); Sarcoma, 2 (0.6%); Vaginal, 2 (0.6%); Brain, 1 (0.3%); Myelodysplasia, 1 (0.3%); Renal Cell, 1 (0.3%); Thymus, 1 (0.3%); Vulvar, 1 (0.3%).